Skip to content

Establishment of Post-Stroke Cognitive Impairment Precision Assessment System and Multi-modal Non-Invasive Brain Stimulation Standardized Treatment System

Establishment of Post-Stroke Cognitive Impairment Precision Assessment System and Multi-modal Non-Invasive Brain Stimulation Standardized Treatment System

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000036855
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke cognitive impairment

Interventions

TMS group:transcranial magnetic stimulation+ cognitive training
tDCS group:transcranial direct currents stimulation+ cognitive training
cognitive training group:none
health control group(tDCS):transcranial direct currents stimulation
health control group(TMS):Transcranial magnetic stimulation

Sponsors

Huashan Hospital, Fudan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Post-Stroke Cognitive Impairment Patients: 1. Aged 18 to 75 years; 2. Post cerebral infarction or cerebral hemorrhage, onset time 1 to 12 months; 3. Patients with Cerebrovascular diseases; 4. Patients with first stroke or previous stroke without sequelae; 5. Confirmed stroke by head CT or MRI, and exclude obvious neuropathies (such as encephalitis, hydrocephalus, etc.; 6. Cognitive impairment; 7. Cooperate for cognitive test, training, and follow-up; 8. Signed informed consent by the patient or direct family members.? Health Volunteers: 1.Aged 18 to 75 years; 2.Without severe visual or hearing impairment. 3.Without cognitive impairment; 4.Signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients accompanied by unconsciousness, could not cooperate with the examination and treatment; 2. Patients with severe primary diseases in heart, liver, kidney and hematopoietic system; 3. Patients with cognitive impairment due to other non-cerebrovascular diseases; 4. Previous history of mental disorders, substance abuse; 5. Patients with organ failure or severity stroke and cancer and other diseases or conditions that affect the quality of life of patients more than post-stroke cognitive impairment; 6. Patients who are unable to complete treatment, may have poor compliance and difficult to follow up.

Design outcomes

Primary

MeasureTime frame
Functional Near-Infrared Spectroscopy, fNIRS;Electroencephalography, EEG;

Secondary

MeasureTime frame
Mini-Mental State Examination,MMSE;The Montreal Cognitive Assessment, MoCA;activity of daily living, ADL;The Zung Self-Rating Anxiety Scale, SAS;The Zung Self-Rating Depression Scale, SDS;Auditory Verbal Learning Test, AVLT;Rey-Osterrieth Complex Figure Test, CFT;Clock drawing test, CDT;Boston naming test, BNT;verbal fluency test, VFT;Trail Making Test, TMT;

Countries

China

Contacts

Public ContactWu Yi

Department of Rehabilitation Medicine, Huashan Hospital, Fudan University

Wuyi4000@163.com+86 13003176229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026